[HLA-A*1101 & B2M & KRASG12C (VVVGACGVGK)

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
HB-0056HB-0056; HB0056Phase 1 ClinicalShanghai Huaota Biopharmaceutical Co LtdAsthma
Details
9MW38119MW3811Phase 1 ClinicalMabwell (Shanghai) Bioscience Co LtdSolid tumours; Idiopathic Pulmonary Fibrosis; Neoplasms; Fibrosis; Pulmonary Fibrosis
Details
LASN-03Lassen Therapeutics
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Recombinant human interleukin-11 (Hangzhou Jiuyuan Gene Engineering Co Ltd )ApprovedThrombocytopenia
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8